Phase I Trial Using Thymosin Fraction 5 in Renal Cancer
A number of laboratories have now isolated and purified thymic hormone-like factors from animal tissues and blood. These thymic hormones may have the potential to mature precursor lymphocytes to adult functioning cells. This effect could be advantageous for cancer patients to reverse the immunosuppressive effects of chemotherapy, radiotherapy, surgery, and of the tumor itself (W. Wara et al., 1975).
KeywordsRenal Cell Carcinoma Brain Metastasis Small Cell Carcinoma Renal Cell Carcinoma Patient Thymic Hormone
Unable to display preview. Download preview PDF.
- Wara, W. M., Phillips, T. L., Wara, D. W., Ammann, A. J., and Smith, V., 1975, Immunosuppression following radiation therapy for carcinoma of nasopharynx, Am. J. Roentgenol. 123:482–485.Google Scholar
- Wara, W. M., Neely, M. H., Ammann, A. J., and Wara, D. W., 1981, Thymosin adjuvant therapy in advanced head and neck cancer, in: Adjuvant Therapy of Cancer III (S. E. Salmon and S. E. Jones, eds.), pp. 169–173, Grune & Stratton, New York.Google Scholar